These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21255898)

  • 1. One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction.
    Bodí V; Rumiz E; Merlos P; Nunez J; López-Lereu MP; Monmeneu JV; Chaustre F; Moratal D; Trapero I; Blasco ML; Oltra R; Sanjuán R; Chorro FJ; Llàcer A; Sanchis J
    Rev Esp Cardiol; 2011 Feb; 64(2):111-20. PubMed ID: 21255898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.
    Husser O; Bodi V; Sanchis J; Nunez J; Mainar L; Rumiz E; Lopez-Lereu MP; Monmeneu JV; Forteza MJ; Oltra R; Riegger GA; Chorro FJ; Llacer A
    Thromb Res; 2009 Nov; 124(5):592-600. PubMed ID: 19540571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximum persisting single lead ST elevation after primary angioplasty: a good predictor of left ventricular dilatation assessed by magnetic resonance imaging.
    Barbieri A; Bursi F; Politi L; Rossi L; Fiocchi F; Ligabue G; Manicardi C; Torricelli P; Modena MG
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1113-9. PubMed ID: 18852583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
    Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Brzozowska-Czarnek A; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
    J Electrocardiol; 2009; 42(2):152-6. PubMed ID: 19167012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
    Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
    J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction.
    Claeys MJ; de Meester A; Convens C; Dubois P; Boland J; De Raedt H; Vranckx P; Coussement P; Gevaert S; Sinnaeve P; Evrard P; Beauloye C; Renard M; Vrints C
    Arch Intern Med; 2011 Mar; 171(6):544-9. PubMed ID: 21444843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction.
    Napodano M; Tarantini G; Ramondo A; Cacciavillani L; Corbetti F; Marra MP; Fraccaro C; Peluso D; Razzolini R; Iliceto S
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):44-50. PubMed ID: 19145116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Cantor WJ; Fitchett D; Borgundvaag B; Heffernan M; Cohen EA; Morrison LJ; Ducas J; Langer A; Mehta S; Lazzam C; Schwartz B; Dzavik V; Goodman SG
    Am Heart J; 2008 Jan; 155(1):19-25. PubMed ID: 18082484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance.
    Eitel I; Blase P; Adams V; Hildebrand L; Desch S; Schuler G; Thiele H
    Heart; 2011 Apr; 97(8):632-40. PubMed ID: 21345844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of post-infarction salvaged myocardium by cardiac magnetic resonance. Predictors and influence on adverse ventricular remodeling.
    Monmeneu JV; Bodí V; López-Lereu MP; Sanchis J; Núñez J; Chaustre F; Husser O; Merlos P; Bonanad C; Miñana G; Chorro FJ; Llácer A
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):634-41. PubMed ID: 22579424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.
    Haeck JD; Kuijt WJ; Koch KT; Bilodeau L; Henriques JP; Rohling WJ; Baan J; Vis MM; Nijveldt R; van Geloven N; Groenink M; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
    Heart; 2010 Feb; 96(3):190-5. PubMed ID: 19858136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance.
    Larose E; Rodés-Cabau J; Pibarot P; Rinfret S; Proulx G; Nguyen CM; Déry JP; Gleeton O; Roy L; Noël B; Barbeau G; Rouleau J; Boudreault JR; Amyot M; De Larochellière R; Bertrand OF
    J Am Coll Cardiol; 2010 Jun; 55(22):2459-69. PubMed ID: 20510213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy.
    Mistry N; Bøhmer E; Hoffmann P; Müller C; Bjørnerheim R; Kjeldsen SE; Halvorsen S
    Am Heart J; 2010 Jul; 160(1):73-9. PubMed ID: 20598975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure post-myocardial infarction: a review of the issues.
    Dargie H
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii3-6; discussion ii31, ii43-8. PubMed ID: 15831607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.